Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 2Uterine Prolapse 1Urologic Neoplasms 1Renal Insufficiency, Chronic 1Prostatic Neoplasms 1Neuromuscular Blockade 1Leiomyoma 1Intestinal Obstruction 1Esophageal Neoplasms 1Endometriosis 1Endobronchial Metastases 1Cholecystitis 1

Interventions

Sugammadex 2Neostigmine 2zidovudine 5'-monophosphate-mannose-albumin conjugate 1galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 1Surveys and Questionnaires 1Rocuronium 1Ringer's acetate 1Glycopyrrolate 1Albumins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Urologic Neoplasms × Rocuronium × Clear all
NCT03138967 2020-09-22

Investigation of Sugammadex in Outpatient Urological Procedures

M.D. Anderson Cancer Center

Phase 4 Completed
54 enrolled 12 charts
Genitourinary

Urinary Bladder Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡